Work Area: IP public policy

Latest content

Gilead scores major victory in controversial $1 billion dispute with US government

Delaware jury rules against the federal government in a big-money patent infringement suit being closely watched by policymakers.

11 May 2023

Canadian legislation provides better privacy, bans rogue robots and levies serious fines

Chief IP officers at global companies should not ignore Bill C-27, the new Canadian Digital Charter Implementation Act

09 May 2023

Examining the court data linking Unified Patents' PTAB petitions with its members

The USPTO’s proposed rulemaking package and its potential impact promoted a deep dive on Docket Navigator

08 May 2023

Breath of fresh air: I hear pro-patentee talk from Washington DC

Saturday opinion: Recent dialogue about the US patent system mimics patent holders’ passion for  the virtuous cycle of innovation

06 May 2023

US government confirms concerns over EC SEP licensing regulation

Commerce Secretary Gina Raimondo reveals that officials have told Brussels of worries about aspects of the proposed legislation

04 May 2023

There is still time for a rethink on the EU’s proposed SEP licensing regulation

Fiery language aimed at patent holders by DG Grow chief Thierry Breton cannot mask the lack of evidence supporting the need for legislation

04 May 2023

Moderna’s ongoing struggles over covid infringement liability have broader implications

The vaccine maker has suffered another setback, but its fight to deflect infringement responsibility to the US government continues

02 May 2023

Some gold nuggets for patentees in the PTAB reform proposal

Saturday Opinion: Discretionary denial of IPRs with co-pending litigation will benefit IP owners but some provisions contradict statutory authority

29 April 2023

US PTAB reform proposal comes under fire at House hearing

Congress members grilled USPTO Director Kathi Vidal for rule-making proposals that they view as outside the statutory authority of the America Invents Act

28 April 2023

European Commission proposes unitary SPC as part of mixed bag of pharma IP reforms

Planned change will make UPC more attractive to life sciences companies

28 April 2023

Unlock unlimited access to all IAM content